New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
05:55 EDTCCE, CCE, TDC, TDC, HOT, HOT, SNA, SNA, SNI, SNI, PM, PM, NBL, NBL, FLIR, FLIR, CTSH, CTSH, S, S, IFF, IFF, EXC, EXC, CI, CI, XYL, XYLCompanies reporting Before the Market Open on Thursday, February 7th
Notable companies reporting before the opening bell include Cigna (CI), Coca-Cola Enterprises (CCE), Cognizant (CTSH), Exelon (EXC), Flir Systems (FLIR), International Flavors (IFF), Noble Energy (NBL), Philip Morris (PM), Scripps Networks (SNI), Snap-On (SNA), Sprint (S), Starwood Hotels (HOT), Teradata (TDC) and Xylem (XYL).
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
September 24, 2015
14:04 EDTSSprint CEO expects to have adequate supply of new iPhones, Re/code says
Subscribe for More Information
13:01 EDTCICigna, UT Medical Center expand network agreement for 2016
Subscribe for More Information
12:34 EDTSSprint volatility at one-year high
Sprint October weekly call option implied volatility is at 78, October is at 71, November is at 72; compared to its 52-week range of 37 to 75, suggesting large price movement.
10:17 EDTCICigna becomes first U.S. health insurer to sign UN Global Compact
Subscribe for More Information
09:22 EDTSSprint to offer iPhone 6s 16GB for $1 per month
Subscribe for More Information
08:19 EDTEXCExelon weakness overdone, says RBC Capital
Subscribe for More Information
08:04 EDTXYLXylem sees FY15 adjusted EPS $1.82-$1.87, consensus $1.84
Sees FY15 revenue approx. $3.7B, consensus $3.66B. On an organic basis, Xylem expects to generate revenue growth of approximately one to two percent. Full-year 2015 adjusted operating income is expected to be in the range of $470 million to $483 million. Excluding the projected unfavorable impact of foreign exchange translation, Xylem's adjusted earnings per share growth expectations are in the range of four to seven percent over the comparable full-year 2014 results. The Company's outlook for projected restructuring and realignment costs of $20 million for the year is unchanged. "Xylem has a powerful arsenal to fuel our growth and create value for our shareholders," said CEO Patrick Decker. "First, the combination of improving end-market conditions and diligent execution will enable us to deliver faster than market growth. Second, we expect to further expand operating margins by more than 300 basis points over the next five years through focused business simplification and continuous improvement initiatives. And finally, we plan to execute a balanced capital deployment strategy. With strong cash flow and a solid capital structure, we expect to deploy up to $3.5 billion for disciplined M&A and opportunistic share repurchases over the plan period."
08:03 EDTXYLXylem reaffirms FY outlook at Investor & Analyst Day
07:41 EDTEXCMitsubishi UFJ to hold a conference
Subscribe for More Information
06:30 EDTSAltice to aggressively expand presence with Cablevision buy, Variety says
Altice's (ATCEY) proposal to acquire Cablevision (CVC) is a signal that Altice founder Patrick Drahi intends to extend his vision across the Atlantic, Variety says. Altice may just be getting started when it comes to shopping for U.S. media assets, and has already snatched some $40B worth of cable, wireless and telecom assets over the past two years, the report says. There's talk of Altice also going after a wireless firm such as Sprint (S) or T-Mobile (TMUS) to further its strategy for growth, the report says. Reference Link
September 23, 2015
08:48 EDTHOTStarwood makes debut in Montana
Starwood Hotels & Resorts announced the debut of its eco-wise Element brand in Bozeman with the opening of Element Bozeman, marking the first Starwood hotel in the state of Montana. Owned by a group of Bozeman investors, the newly constructed Element hotel offers a stylish and sustainable new option for travelers with 104 light-filled rooms and an atmosphere designed to fuel a life in balance while on the road.
08:46 EDTSNASnap-On management to meet with Barrington
Subscribe for More Information
08:11 EDTCILeerink sees less political risk for Managed Care mergers after hearings
Subscribe for More Information
07:10 EDTEXCExelon weakness creates buying opportunity, says SunTrust
Subscribe for More Information
September 22, 2015
20:02 EDTCIClinton vows $250 cap on monthly drug costs in blast against biotechs, insurers
Democratic presidential candidate Hillary Clinton railed against biotech companies as well as health insurers at a community health care forum in Iowa on Tuesday. Clinton began her speech by praising the Affordable Care Act, but quickly noted that she wants to strengthen it due to what she called the rising cost of prescription drugs. She explained, "Our pharmaceutical and biotechnology industries deserve credit... [But] too often, these drugs cost a fortune. Now, sometimes there is a good reason for that. Scientific breakthroughs are often the result of major investment... so it may makes sense, for a short period of time, to have to charge a lot of money for a drug. But when a drug has no competition, when there aren't any other treatments that can do what it does, pharmaceutical companies can charge astronomical fees far beyond anything that it would take to recoup their investment, and far beyond what they charge consumers anywhere else in the world outside of America." Referencing the recent criticism against Turing Pharmaceuticals, Clinton went on to say that "pharmaceutical companies that acquire an existing affordable drug that people rely on, and then turn around and charge a fortune for it, [are just betting] on the fact that desperate people will find some way to pay for it." Preemptively responding to questions of whether greater regulation will dampen investment, Clinton commented that "some people worry that my proposals will threaten innovation, but I have designed a plan that will do exactly the opposite... Under my plan, drug companies that want to keep getting federal support will have to redirect more of their profits into meaningful investments in research and development." Clinton also criticized incremental drug improvements, saying that "too often, so-called new drugs are really old drugs that have just been tweaked a little bit, but then they're marketed as breakthrough drugs and they're sold for high prices." The Democratic candidate went on to condemn advertising in the drug industry, remarking that "I also want to tackle direct to consumer advertising... Other countries ban these ads because they are so often misleading. But at the very least, we shouldn't be encouraging them with corporate write-offs... Under my plan, we will instead use that taxpayer money to fund innovation... I would also like to make sure any ads the drug industry does run are approved by the FDA." Moving more broadly onto Medicaid and health insurers, Clinton stated, "I believe Medicare should be able to negotiate for lower prices for its members... I will require drug companies to provide higher rebates for prescription drugs to low income Medicare patients, just like they have to do for Medicaid patients... I think the insurance companies need to be put on notice." Providing more concrete details of her plan, Clinton concluded, "I will cap out of pocket drug costs for working families. You won't have to pay more than $250 a month for covered medications... Particularly for people who have a chronic illness. Also under my plan, you will be able to import cheaper drugs from other countries legally. If the medicine you need costs less in Canada, you should be able to buy it from Canada or any other country that meets our safety standards... I will also make sure we have more generics on the market [by boosting funding for] the FDA's office of generic drugs."
10:29 EDTXYLXylem to host analyst and investor day
Subscribe for More Information
09:13 EDTHOTStarwood to expand presence in Brazil with signing of Sheraton Santos Hotel
Subscribe for More Information
09:06 EDTHOTStarwood expands in Brazil with signing of Sheraton Santos Hotel
Starwood announced its presence in Brazil will expand with the signing of Sheraton Santos Hotel, owned by local real estate developer Grupo Mendes. The signing comes on the heels of the recent reopening of Sheraton Barra Rio de Janeiro Hotel in May and, fitting for the Sheraton brand, will be the first international upper-upscale hotel in Santos in the state of Sao Paulo.
08:44 EDTCICigna price target raised to $160 from $145 at Cowen
Cowen raised its price target on Cigna (CI) to $160 from $145 citing its accretion with Anthem (ANTM). The firm said they see limited downside if the deal does not go through and substantial upside if the deal does go through. Cowen reiterated its Outperform rating on Cigna shares.
08:37 EDTCIAetna, Anthem CEOs set to testify to Senate committee, WSJ reports
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use